Cargando…

Eyeing non-alcoholic fatty liver disease: The noninvasive way

Detalles Bibliográficos
Autor principal:	Gude, Dilip
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2011
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3657972/ https://www.ncbi.nlm.nih.gov/pubmed/23776795 http://dx.doi.org/10.4103/2229-516X.91164

Ejemplares similares

Noninvasive Imaging for the Evaluation of Non-Alcoholic Fatty Liver Disease Spectrum
por: Liu, Qianjiao, et al.
Publicado: (2021)

Body Composition and Non-alcoholic Fatty Liver Disease
por: Abenavoli, Ludovico, et al.
Publicado: (2016)

Alcohol and fertility
por: Gude, Dilip
Publicado: (2012)

Silymarin: An option to treat non-alcoholic fatty liver disease
por: Colica, Carmela, et al.
Publicado: (2017)

Lean non-alcoholic fatty liver disease: do not forget diabetes
por: Patoulias, Dimitrios Ioannis, et al.
Publicado: (2019)

Non-alcoholic fatty liver disease, diabetes medications and blood pressure
por: Ilias, Ioannis, et al.
Publicado: (2021)

Letter regarding “Non-alcoholic fatty liver disease: Definition and subtypes”
por: Jeong, Seogsong, et al.
Publicado: (2023)

Multipronged Approach to Assess Risk Factors for Non-alcoholic Fatty Liver Disease
por: Hidrus, Aizuddin, et al.
Publicado: (2022)

Fighting microbes the ‘Nano’ way
por: Gude, Dilip
Publicado: (2011)

Comments on Prevalence of Non-alcoholic Fatty Liver Disease and Its Related Factors in Iran
por: Karimi-Sari, H., et al.
Publicado: (2017)

Do artificial sweeteners increase the risk of non-alcoholic fatty liver disease (NAFLD)?
por: Abbas, Tahany, et al.
Publicado: (2020)

Assessing causal relationships between COVID-19 and non-alcoholic fatty liver disease
por: Liu, Dong, et al.
Publicado: (2022)

Serum leptin in non-alcoholic fatty liver disease: Ambiguous clinical implications concerning cardiovascular disease
por: Patoulias, Dimitrios, et al.
Publicado: (2019)

Non-alcoholic fatty liver disease and the risk of dementia: A meta-analysis of cohort studies
por: Lu, Li-Yu, et al.
Publicado: (2022)

Non-alcoholic fatty liver disease in patients with inflammatory bowel disease might boost cardiovascular disease burden
por: Patoulias, Dimitrios Ioannis
Publicado: (2019)

Diet and Non-Alcoholic Fatty Liver Disease: The Mediterranean Way
por: Abenavoli, Ludovico, et al.
Publicado: (2019)

Liraglutide for non-alcoholic fatty liver disease in children and adolescents: has a new era arrived?
por: Patoulias, Dimitrios Ioannis
Publicado: (2019)

Empagliflozin promises to bridge the gap between non-alcoholic fatty liver disease, type 2 diabetes, and cardiovascular disease
por: Patoulias, Dimitrios, et al.
Publicado: (2018)

Lean non-alcoholic fatty liver disease: Is there a place for novel antidiabetics in the therapeutic management of this underappreciated “enemy”?
por: Patoulias, Dimitrios, et al.
Publicado: (2020)

Non-alcoholic fatty liver disease and risk of dementia: Unmet need for a pooled analysis of cohort studies
por: Jeong, Seogsong, et al.
Publicado: (2022)

Noninvasive ventilation in acute respiratory distress syndrome: A long way ahead
por: Sehgal, Inderpaul Singh, et al.
Publicado: (2016)

Letter regarding “The usefulness of metabolic score for insulin resistance for the prediction of incident non-alcoholic fatty liver disease in Korean adults”
por: Lee, Hye Won
Publicado: (2023)

Non-alcoholic fatty liver disease may be associated with endothelial dysfunction
por: Balta, Sevket, et al.
Publicado: (2014)

Endothelial dysfunction and carotid atherosclerosis in non-alcoholic fatty liver disease
por: Dogru, Teoman, et al.
Publicado: (2014)

Is Ki-67 a prognostic factor for post-operation survival in patients with non-alcoholic fatty liver disease-associated hepatocellular carcinoma?
por: Li, Changcan, et al.
Publicado: (2022)

Correspondence on Letter regarding “The usefulness of metabolic score for insulin resistance for the prediction of incident non-alcoholic fatty liver disease in Korean adults”
por: Lee, Jun-Hyuk, et al.
Publicado: (2023)

A proteo-transcriptomic map of non-alcoholic fatty liver disease signatures
por: Govaere, Olivier, et al.
Publicado: (2023)

Faecal Microbiota Transplantation, Paving the Way to Treat Non-Alcoholic Fatty Liver Disease
por: Del Barrio, María, et al.
Publicado: (2023)

Urinary lithogenic profile of patients with non-alcoholic fatty liver disease
por: Bargagli, Matteo, et al.
Publicado: (2023)

Endocrine disruptors: Ubiquitous, yet less known
por: Gude, Dilip
Publicado: (2011)

Alopecia Areata – Probing the Deforestation
por: Gude, Dilip
Publicado: (2011)

To ‘umbrella’ the gonads in transfusion rain
por: Gude, Dilip
Publicado: (2011)

Thyroid and its indispensability in fertility
por: Gude, Dilip
Publicado: (2011)

Epilepsy, anti-epileptic drugs and bone health in children
por: Gude, Dilip
Publicado: (2011)

On “ruby” in myocardial perfusion imaging
por: Gude, Dilip
Publicado: (2011)

We are what we breathe!
por: Gude, Dilip
Publicado: (2011)

Hair Follicle Stem Cells: A New Arena
por: Gude, Dilip
Publicado: (2011)

Stories that Hair can Tell
por: Gude, Dilip
Publicado: (2011)

Hair - A Yardstick for Diabetes
por: Gude, Dilip
Publicado: (2011)

‘Tracing Elements’ in Hair
por: Gude, Dilip
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_d92gpnqddgls427qobu8uov3sg